Title	Publication Date	Language	Citations
Notice of Retraction: Acharya P, Chen J-J, Correia MA (2010) Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2α kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone. Mol Pharmacol 77(4):575–592; doi:10.1124/mol.109.061259.	2021/08/01	English
Notice of Retraction: Acharya P, Engel JC, Correia MA (2009) Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: A consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2α (eIF2α)-kinase (PERK) and general control nonderepressible-2 eIF2α kinase (GCN2), and global translational shutoff. Mol Pharmacol 76(3):503–515; DOI: https://doi.org/10.1124/mol.109.056002.	2021/08/01	English
Correction to “Activation of the Orphan G Protein–Coupled Receptor GPR27 by Surrogate Ligands Promotes β-Arrestin 2 Recruitment”	2022/03/23	English
Correction to Table of Contents in Volume 84, Number 1	2013/07/16	English
Correction to “Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo”	2011/04/19	English
Correction to: “Preclinical Evaluation of DMA, a Bisbenzimidazole, as Radioprotector: Toxicity, Pharmacokinetics, and Biodistribution Studies in Balb/c Mice”	2015/09/08	English
Correction to “Exon 3 Splicing and Mutagenesis Identify Residues Influencing Cell Surface Density of Heterologously Expressed Silkworm (Bombyx mori) Glutamate-Gated Chloride Channels”	2014/11/25	English
Re: Ling Y-H, Lin R, and Perez-Soler R (2008) Erlotinib Induces Mitochondrial-Mediated Apoptosis in Human H3255 Non-Small-Cell Lung Cancer Cells with Epidermal Growth Factor ReceptorL858R Mutation through Mitochondrial Oxidative Phosphorylation-Dependent Activation of BAX and BAK Mol Pharmacol 74:793–806; doi:10.1124/mol.107.044396	2015/06/30	English
Re: Ling Y-H, Li T, Yuan Z, Haigentz M, Jr., Weber TK, and Perez-Soler R (2007) Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with Cell Growth Inhibition and G1/S Phase Arrest in Human Non-Small-Cell Lung Cancer Cell Lines. Mol Pharmacol 72:248–258; doi:10.1124/mol.107.034827	2015/06/30	English
Correction to “Deletion of Microsomal Cytochrome b5 Profoundly Affects Hepatic and Extrahepatic Drug Metabolism”	2013/12/12	English
Correction to “Evidence that γ-Secretase-Mediated Notch Signaling Induces Neuronal Cell Death via the Nuclear Factor-κB-Bcl-2-Interacting Mediator of Cell Death Pathway in Ischemic Stroke”	2011/08/19	English
More Hints on Wnts: Gene Profiling by β2-Adrenergic Receptor-Frizzled Chimeras: Fig. 1.	2004/01/01	English
Response to Comments on “Calpain Mediates the Dioxin-Induced Activation and Down-Regulation of the Aryl Hydrocarbon Receptor”	2006/12/21	English
Comments on “Calpain Mediates the Dioxin-Induced Activation and Down-Regulation of the Aryl Hydrocarbon Receptor”	2006/12/21	English
Re: Henschler R, Brennscheidt U, Mertelsmann R, and Herrmann F (1991) Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-β-d-arabinofuranosylcytosine. Mol Pharmacol 39:171-176	2006/12/21	English
Potentiation of Acetylcholine Receptors by Divalent Cations: Fig. 1.	2006/04/26	English
Correction to “Aryl Hydrocarbon Receptor Regulates Distinct Dioxin-Dependent and Dioxin-Independent Gene Batteries”	2006/10/20	English
Correction to “A Functional Steroid-Binding Element in an ATP-Binding Cassette Multidrug Transporter”	2008/07/22	English
Correction to “Molecular Interaction of a Potent Nonpeptide Agonist with the Chemokine Receptor CCR8”	2008/07/22	English
Correction to “Induction of Apoptosis by Vinblastine via c-Jun Autoamplification and p53-Independent Down-Regulation of p21WAF1/CIP1”	2008/07/22	English
Up-Regulation of Insulin Receptor Substrate-1 and -2 by Neuronal Nicotinic Receptor-Induced Sequential Activation of Protein Kinase C-  and Extracellular Signal-Regulated Kinase (ERK): Enhancement of Insulin-Induced Phosphoinositide 3-Kinase and ERK Signaling Pathways in Adrenal Chromaffin Cells	2005/04/22	English
Editors' Note regarding “Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists”	2003/07/01	English
Correction to “Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor”	2003/07/01	English
Correction to “Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole”	2003/08/14	English
Correction to “Prostacylin receptor activation inhibits proliferation of aortic smooth muscle cells by regulating cAMP response element-binding protein- and pocket protein-dependent cyclin A gene expression”	2003/08/14	English
Correction to “A Dopamine D2 Receptor Mutant Capable of G Protein-Mediated Signaling but Deficient in Arrestin Binding”	2009/02/19	English
Correction to “Capacitative Ca2+ Entry via Orai1 and Stromal Interacting Molecule 1 (STIM1) Regulates Adenylyl Cyclase Type 8”: Fig. 4.	2009/04/23	English
Correction to “Phoneutria nigriventer Toxin 1: A Novel, State-Dependent Inhibitor of Neuronal Sodium Channels That Interacts with μ Conotoxin Binding Sites”	2007/08/23	English
Correction to “Chromanol 293B Binding in KCNQ1 (Kv7.1) Channels Involves Electrostatic Interactions with a Potassium Ion in the Selectivity Filter”	2007/08/23	English
Correction to “Investigation into the Mechanism of Homo- and Heterodimerization of Angiotensin-Converting Enzyme”	2018/03/30	English